The Biden Administration has reached a $231 million deal with Ellume for its rapid, at-home, over-the-counter test for SARS-CoV-2, as 360Dx reports.
The Biden Administration has reached a $231 million deal with Ellume for its rapid, at-home, over-the-counter test for SARS-CoV-2, as 360Dx reports.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.